SavedAdd your journal

Journals / Turkish Journal of Hematology / 2019 / Cilt: 36 - Sayı: 3

MDM2 Oncogene Copy Number Alterations in Chronic Lymphocytic Leukemia

Kronik Lenfositik Lösemide MDM2 Onkogen Kopya Sayısı Değişiklikleri

Pathum SOOKAROMDEE, Viroj WIWANITKIT

Pages
220–220
DOI
—

Abstract

1. Darbaş Ş, Aydın Ç, Salim O, Berker Karaüzüm S. Investigation of MDM2oncogene copy number alterations in cases of chronic lymphocyticleukemia. Turk J Hematol 2019;36:126-127.2. Bixby D, Kujawski L, Wang S, Malek SN. The pre-clinical development ofMDM2 inhibitors in chronic lymphocytic leukemia uncovers a central rolefor p53 status in sensitivity to MDM2 inhibitor-mediated apoptosis. CellCycle 2008;7:971-979.3. Watanabe T, Ichikawa A, Saito H, Hotta T. Overexpression of the MDM2oncogene in leukemia and lymphoma. Leuk Lymphoma 1996;21:391-397.